`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`
`
`
`REGENERON PHARMACEUTICALS, INC.,
`
`
`
`Plaintiff/Counter-Defendant,
`
`
`v.
`
`
`
`
`
`
`
`
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`
`
`
`Defendant/Counter-Claimant.
`
`
` CIVIL NO. 1:22-CV-61
`
`
` (KLEEH)
`
`ORDER
`For good cause, the motion to intervene filed by Amgen USA,
`
`Inc. (“Amgen”) is GRANTED [ECF No. 485]. The parties and Amgen
`are ORDERED to meet and confer after the bench trial takes place,
`but on or before August 18, 2023, to determine which documents on
`the docket can be unsealed and/or redacted. The parties and Amgen
`shall submit a filing with the Court on or before August 25, 2023,
`indicating which documents can be unsealed and/or redacted.
`It is so ORDERED.
`
`The Clerk is DIRECTED to transmit copies of this Order to
`
`counsel of record, including counsel for Amgen.
`
`DATED: May 31, 2023
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`____________________________
`THOMAS S. KLEEH, CHIEF JUDGE
`NORTHERN DISTRICT OF WEST VIRGINIA
`
`